object
late
decemb
outbreak
coronaviru
diseas
wuhan
china
caus
novel
coronaviru
newli
name
sever
acut
respiratori
syndrom
coronaviru
aim
quantifi
sever
infect
highresolut
chest
comput
tomographi
ct
determin
relationship
clinic
paramet
materi
method
januari
februari
clinic
laboratori
highresolut
ct
featur
patient
year
male
analyz
initi
followup
ct
obtain
mean
day
day
ill
onset
retrospect
assess
sever
progress
pneumonia
correl
among
clinic
paramet
initi
ct
featur
progress
opacif
evalu
spearman
correl
linear
regress
analysi
result
thirtyf
patient
exhibit
progress
process
accord
ct
featur
earli
stage
onset
followup
ct
find
show
progress
opacif
consolid
interstiti
thicken
fibrou
strip
air
bronchogram
compar
initi
ct
p
regular
treatment
moder
correl
day
onset
sum
score
opacif
r
p
creactiv
protein
erythrocyt
sediment
rate
lactat
dehydrogenas
show
significantli
posit
correl
sever
pneumonia
assess
initi
ct
r
rang
p
highest
temperatur
sever
opacif
assess
initi
ct
significantli
relat
progress
opacif
followup
ct
p
conclus
patient
infect
usual
present
typic
ground
glass
opac
ct
featur
show
signific
correl
clinic
laboratori
measur
followup
ct
imag
often
demonstr
progress
earli
stage
ill
onset
n
late
decemb
wuhan
china
becam
center
outbreak
pneumonia
caus
novel
coronaviru
newli
name
sever
acut
respiratori
syndrom
coronaviru
diseas
spread
strike
speed
institut
first
case
discov
late
decemb
februari
confirm
case
china
exceed
short
period
approxim
hubei
provinc
case
pneumonia
also
report
worldwid
emerg
urgent
coronaviru
diseas
rais
intens
attent
global
belong
famili
coronavirida
includ
virus
caus
diseas
rang
common
influenza
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
accord
epidemiolog
investig
virus
highli
infecti
spread
rapidli
human
main
rout
transmiss
via
respiratori
droplet
well
physic
contact
current
estim
incub
period
gener
day
day
peopl
gener
suscept
elderli
underli
diseas
serious
ill
infect
children
infant
also
infect
highli
homolog
sarscov
may
caus
sever
ill
similar
clinic
sar
earli
diseas
progress
rapid
sometim
result
sever
respiratori
distress
syndrom
intens
care
unit
admiss
death
chines
health
author
immedi
investig
implement
import
measur
character
novel
pneumonia
restrict
preval
mani
citi
hubei
provinc
seal
outsid
contact
stop
spread
plagu
meanwhil
effici
diagnosi
treatment
procedur
develop
symptom
result
infect
prodrom
phase
includ
fever
dri
cough
malais
nonspecif
patient
may
even
obviou
symptom
therefor
chest
comput
tomographi
ct
particular
highresolut
comput
tomographi
hrct
repres
valuabl
tool
identifi
patient
infect
earli
stage
clinic
symptom
may
unspecif
spars
everi
suspect
patient
chest
ct
indispens
definit
diagnosi
reexamin
accord
world
health
organ
center
diseas
control
prevent
guidelin
chest
radiographi
ctwere
major
diagnost
compon
sar
preval
clinic
imag
manifest
earli
stage
particularli
import
use
confirm
diagnosi
judg
chang
sever
adjust
treatment
plan
infer
prognosi
purpos
studi
character
clinic
hrct
featur
patient
infect
retrospect
facilit
earli
identif
earli
isol
also
aim
explor
chang
hrct
shortterm
followup
whether
connect
clinic
imag
featur
earli
stage
ill
institut
review
board
approv
retrospect
studi
inform
consent
waiv
studi
involv
potenti
risk
patient
januari
februari
patient
suspect
diagnosi
viral
pneumonia
underw
chest
hrct
scan
institut
ensur
qualiti
integr
clinic
laboratori
imag
data
includ
patient
admit
tongji
hospit
januari
februari
diagnosi
infect
confirm
posit
result
realtim
fluoresc
polymeras
chain
reaction
assay
nucleic
acid
nasopharyng
oropharyng
swab
specimen
case
lung
surgeri
lung
tumor
histori
caus
pneumonia
common
bacteri
viral
pathogen
exclud
retrospect
collect
clinic
laboratori
data
specif
includ
sign
symptom
white
blood
cell
count
neutrophil
count
lymphocyt
count
creactiv
protein
crp
level
erythrocyt
sediment
rate
esr
lactat
dehydrogenas
ldh
level
procalcitonin
level
ddimer
level
chest
ct
imag
obtain
use
scanner
lightspe
plu
ge
medic
system
milwauke
wi
aquilion
one
toshiba
medic
system
tokyo
japan
uct
unit
imag
shanghai
china
tube
voltag
kv
kv
automat
tube
current
modul
use
imag
reconstruct
slice
thick
mm
mm
interv
mm
mm
respect
patient
underw
initi
ct
averag
day
rang
day
onset
symptom
accord
nation
health
health
commiss
also
underw
followup
ct
scan
evalu
progress
diseas
short
period
standard
treatment
mean
interv
time
initi
followup
examin
day
rang
day
ct
imag
review
radiologist
ds
yx
xl
year
clinic
experi
respect
use
pictur
archiv
commun
system
highresolut
ct
imag
review
window
width
level
hu
hu
respect
lung
parenchyma
hu
hu
respect
mediastinum
decis
reach
consensu
patient
initi
followup
ct
imag
evalu
follow
presenc
ground
glass
opac
ggo
consolid
interstiti
thicken
reticul
fibrou
stripe
air
bronchogram
sever
opacif
manifest
locat
lesion
peripher
central
central
peripher
pleural
effus
mediastin
lymph
node
chang
enlarg
increas
number
lymph
node
ground
glass
opac
defin
increas
lung
attenu
preserv
bronchial
vascular
margin
consolid
defin
opacif
underli
vasculatur
obscur
lobe
lung
assess
opacif
lesion
size
grade
none
diamet
cm
diamet
cm
diamet
cm
lobe
lobe
lobar
score
sum
calcul
overal
score
sever
opacif
chang
score
initi
followup
ct
calcul
qualifi
chang
opacif
time
chang
lung
opacif
followup
ct
scan
categor
increas
decreas
stabl
extent
furthermor
largest
crosssect
obviou
lesion
lung
initi
ct
delin
follow
area
squar
millimet
densiti
hounsfield
unit
maximum
region
interest
record
statist
analysi
procedur
conduct
use
spss
softwar
ibm
armonk
ny
p
consid
statist
signific
comparison
initi
followup
hrct
find
made
use
pair
student
test
continu
data
fisher
exact
test
categor
data
correl
coeffici
calcul
clinic
laboratori
find
ct
featur
use
spearman
pearson
correl
appropri
linear
regress
analysi
unadjust
adjust
age
sex
use
identifi
signific
variabl
predict
progress
ddimer
mgl
continu
data
express
mean
sd
categor
data
present
n
nn
n
total
number
patient
avail
data
opacif
lesion
independ
variabl
clinic
laboratori
find
initi
hrct
featur
outcom
variabl
averag
age
male
femal
patient
year
rang
year
old
patient
contact
individu
wuhan
live
wuhan
common
complaint
patient
fever
cough
fatigu
complaint
includ
diarrhea
dyspnea
major
patient
normal
white
blood
cell
count
neutrophil
count
lymphocyt
count
patient
reduc
white
blood
cell
count
reduc
lymphocyt
count
increas
crp
increas
esr
increas
ldh
demograph
data
symptom
laboratori
test
studi
group
list
tabl
data
initi
followup
chest
hrct
imag
find
list
tabl
initi
ct
patient
opac
lobe
patient
lobe
affect
patient
lesion
locat
lower
lobe
left
lower
lobe
vulner
lobe
wherea
right
middl
lobe
least
affect
lobe
studi
dataset
term
locat
lesion
axial
plane
lesion
tend
peripher
central
central
peripher
initi
chest
ct
show
singl
multipl
ggo
case
consolid
interstiti
thicken
reticul
air
bronchogram
pleural
effus
could
also
seen
detail
tabl
fig
initi
chest
ctexamin
sum
score
rang
averag
area
densiti
max
lesion
crosssect
patient
mm
hu
respect
admiss
hospit
regular
treatment
sum
score
posit
correl
day
figur
hrct
imag
admiss
male
patient
day
onset
multipl
ground
glass
opac
ggo
ggo
interlobular
septal
thicken
like
reticul
pave
stone
sign
box
thin
fibrou
stripe
arrow
shown
differ
crosssect
hrct
imag
male
patient
also
medic
personnel
day
onset
diffus
opac
consolid
well
air
bronchogram
arrow
seen
ill
onset
initi
ct
age
sex
covari
r
p
fig
b
case
exhibit
progress
process
accord
ct
studi
time
window
fig
includ
serious
ill
femal
patient
die
day
diseas
onset
seven
patient
exhibit
approxim
unchang
decreas
size
opacif
fig
detail
tabl
followup
ct
singl
ggo
progress
multipl
ground
glass
infiltr
lung
compar
initi
ct
case
consolid
interstiti
thicken
reticul
air
bronchogram
pleural
effus
fibrou
strip
could
seen
p
detail
tabl
diffus
lesion
bilater
lung
could
seen
serious
affect
patient
whose
ct
show
white
lung
fig
sum
score
rang
differ
sum
score
initi
followup
ct
figur
case
progress
admiss
hrct
imag
femal
patient
day
onset
multipl
ggo
distribut
bilater
three
day
later
opac
also
larger
size
seen
bilater
differ
area
densiti
max
lesion
crosssect
initi
followup
ct
b
admiss
treatment
sum
score
posit
correl
day
onset
initi
ct
age
sex
covari
r
p
regular
treatment
correl
longer
signific
p
c
three
differ
case
show
max
lesion
crosssect
initi
followup
ct
averag
area
densiti
max
lesion
crosssect
patient
mm
hu
respect
area
largest
lesion
sum
score
initi
ct
smaller
followup
ct
p
regular
treatment
correl
sum
score
day
ill
onset
ct
examin
signific
age
sex
covari
p
fig
b
continu
follow
patient
investig
notic
case
total
opacif
size
began
reduc
day
ill
onset
also
observ
anoth
patient
whose
ct
carri
day
ill
onset
increas
lung
opacif
still
progress
group
time
specifi
tabl
summar
correl
clinic
laboratori
find
versu
initi
ct
paramet
correl
clinic
find
ct
paramet
weak
includ
correl
age
number
affect
lobe
r
cough
sum
score
r
fever
fatigu
white
blood
cell
count
correl
ct
paramet
p
signific
posit
correl
found
crp
esr
ldh
level
sever
ct
featur
sum
score
area
max
lesion
consolid
air
bronchogram
show
weak
moder
correl
r
rang
fig
signific
associ
found
fever
highest
temperatur
versu
clinic
paramet
versu
fever
increas
risk
progress
opacif
sever
score
followup
time
regress
coeffici
b
p
patient
high
temperatur
associ
time
higher
progress
opacif
sever
score
compar
normal
temperatur
less
b
p
even
adjust
age
sex
b
p
assess
initi
ct
featur
sum
score
max
score
opacif
area
max
lesion
crosssect
appear
interstiti
thicken
show
signific
invers
associ
unadjust
p
rang
ageand
sexadjust
analys
p
rang
detail
tabl
newli
describ
viral
infect
initi
experi
reveal
mani
frequent
find
clinic
symptom
hrct
common
symptom
fever
dri
cough
fatigu
consist
former
report
laboratori
find
normal
decreas
white
blood
cell
count
lymphocyt
count
well
elev
crp
esr
ldh
level
could
also
help
make
diagnosi
investig
includ
current
one
shown
frequent
encount
hrct
find
similar
viral
pneumonia
includ
specif
sar
mer
pneumonia
term
distribut
lower
lobe
preferenti
data
express
mean
sd
n
affect
especi
left
lower
lobe
studi
group
case
initi
onset
stage
pulmonari
lesion
commonli
subpleur
peribronchovascular
area
distribut
diffus
earli
stage
singl
multipl
small
ground
glass
infiltr
consolid
interstiti
thicken
could
seen
diseas
progress
sever
case
consolid
air
bronchogram
relev
lobe
diffus
lesion
shown
white
lung
seen
sever
affect
patient
fibrou
stripe
could
seen
remiss
stage
distribut
manner
togeth
ggo
characterist
impress
clinic
treatment
sum
score
opacif
size
posit
correl
day
ill
onset
initi
ct
therefor
cautiou
attent
symptom
applic
ct
examin
soon
possibl
help
earli
detect
infect
standard
treatment
isol
especi
unawar
conceal
discomfort
hrct
assist
clinician
antiepidem
worker
find
potenti
infecti
patient
individu
treatment
individu
heterogen
correl
signific
admiss
hospit
howev
total
opacif
sever
score
still
increas
rel
slower
speed
treatment
accord
followup
ct
imag
earli
stage
ill
onset
patient
exhibit
progress
advanc
involv
opacif
although
patient
data
r
correl
coeffici
calcul
use
spearman
pearson
correl
appropri
correl
signific
level
signific
level
hospit
regular
treatment
includ
oxygen
inhal
antivir
therapi
corticosteroid
immunoglobulin
therapi
necessari
may
relat
immunopatholog
basi
coronavirus
interact
modifi
host
intracellular
environ
infect
benefit
quickli
replic
major
studi
suggest
dysregulatedexuber
innat
respons
lead
contributor
coronavirusmedi
patholog
mani
cytokin
chemokin
involv
immun
storm
coronaviru
infect
although
meticul
treatment
take
time
immun
respons
build
produc
antibodi
suppress
viru
replic
result
great
import
control
progress
first
week
ill
onset
utmost
effort
studi
sever
laboratori
paramet
includ
specif
esr
crp
ldh
show
signific
posit
correl
sever
pneumonia
quantifi
initi
ct
elev
esr
crp
ldh
level
might
indic
extent
inflamm
extens
tissu
damag
frequent
observ
viral
pneumonia
previou
studi
convalesc
patient
sar
coeffici
confid
interv
ci
indic
chang
sum
score
opacif
everi
unitrefer
increas
variabl
signific
result
boldfac
p
thinsect
ct
score
ggo
interstiti
opac
found
correl
neutrophil
count
crp
ldh
level
guan
et
al
detect
sever
case
promin
elev
level
crp
mgl
vs
p
ldh
ul
vs
p
compar
nonsever
case
multicent
studi
clinic
characterist
patient
laboratoryconfirm
highlight
surveil
case
definit
heavili
focu
fever
detect
consid
patient
fever
initi
present
studi
found
fever
highest
temperatur
relat
abnorm
initi
ct
posit
associ
progress
opacif
followup
ct
mean
day
initi
ct
find
indic
high
fever
initi
present
potenti
risk
factor
advers
ct
outcom
shortterm
followup
howev
limit
case
studi
note
moreov
sever
initi
ct
find
includ
sum
score
max
score
opacif
sever
well
area
max
lesion
crosssect
invers
associ
possibl
explan
result
may
patient
rel
seriou
pulmonari
opac
initi
ct
alreadi
progress
short
plateau
stage
gradual
decreas
trend
abnorm
studi
limit
first
modests
case
seri
patient
admit
hospit
time
data
collect
nucleic
acid
test
diagnosi
covid
yet
avail
suspect
patient
detect
rate
realtim
fluoresc
polymeras
chain
reaction
nucleic
acid
test
high
besid
includ
hospit
patient
followup
ct
examin
ensur
inform
clinic
ct
characterist
possibl
select
bia
note
studi
larger
cohort
requir
obtain
definit
answer
second
quantit
semiquantit
method
measur
pulmonari
lesion
may
certain
subject
third
suscept
consid
initi
incorrectli
low
among
infant
children
adolesc
retrospect
studi
group
effort
made
identifi
clinic
imag
featur
group
futur
studi
conclus
result
studi
confirm
chest
ct
import
diagnosi
manag
infect
despit
meticul
treatment
patient
demonstr
progress
earli
stage
ill
onset
accord
followup
ct
examin
clinic
radiolog
studi
find
show
crp
esr
ldh
level
posit
correl
sever
lung
abnorm
quantifi
initi
ct
moreov
high
fever
associ
advers
followup
ct
outcom
may
add
facet
understand
clinic
express
new
outbreak
familiar
clinic
ct
featur
earli
chang
infect
paramount
import
